Accrued Expenses

12 Months Ended

Dec. 31, 2021

Accrued Expenses

Accrued Expenses

Note 4.Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	December 31,
	2021		2020
Clinical trial expenses	$	2,911,960	$	2,510,111
Other		44,585		128,197
Total	$	2,956,545	$	2,638,308